We respond to NHS England breast cancer waiting times: Q4 of 2019/20 and March 2020

The NHS waiting times quarterly data shows the targets of 93% for the two-week wait for those referred with breast symptoms has been missed:...

14 May 2020

We respond to NICE approval of adjuvant Kadcyla for use on the NHS

The National Institute for Health and Care Excellence (NICE) has today (7 May 2020) approved trastuzumab emtansine (Kadcyla) for routine NHS use for...

7 May 2020

Our response to the coronavirus crisis

Our Chief Executive Delyth Morgan outlines how Breast Cancer Now will continue to support people affected by breast cancer during the coronavirus...

23 March 2020

We respond to to report showing that attendance at breast screening is below the target for second year in Wales

New data on the breast screening programme in Wales was published today (Thursday 12 March) by Public Health Wales in the Breast Test Wales Annual...

13 March 2020

Advice on Coronavirus for people with cancer

Updated: 18 May 2020 This guidance has been produced by the One Cancer Voice* charities in partnership with NHS England. The Government is...

10 March 2020

We respond to new global study suggesting women dissatisfied with breast size also less likely to check themselves

Responding to a new global study (published in the journal 'Body Image') that found women who are dissatisfied with their breast size are...

6 February 2020

We respond to trial showing blood test can quickly match targeted treatments to secondary breast cancer patients

Research presented by Professor Nicholas Turner at the San Antonio Breast Cancer Symposium suggests that a blood test could be used to match patients...

17 December 2019

We respond to study suggesting that ‘oestrogen only and oestrogen plus progestin have opposite effects on breast cancer incidence in post-menopausal women’

Research presented at the San Antonio Breast Cancer Symposium suggests that oestrogen only hormone replacement therapy, otherwise known as HRT, may...

17 December 2019

We respond to major trial showing the preventive effects of anastrozole continue for over five years after women stop taking it

Research presented at the San Antonio Breast Cancer Symposium has shown that the preventative effects of anastrozole, given to some women at high...

17 December 2019